# OnCo record nct06281847 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06281847/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06281847", "NCT06281847" ;
  schema:name "An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia"@en ;
  schema:description "A phase 1/2 trial of CCTx-001 run by Advesya SAS, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06281847/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06281847> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/cctx-001/> ;
  onco:companies <https://onco.cc/companies/advesya/> .